Demand curve analysis of marijuana use among persons living with HIV.

Szczegóły
Abstrakt

Tytuł:: Demand curve analysis of marijuana use among persons living with HIV.
Autorzy:: Greenwald MK; Department of Psychiatry and Behavioral Neurosciences, USA; School of Medicine, Department of Internal Medicine Wayne State University, Detroit, MI 48201, USA. Electronic address: .
Sarvepalli SS; School of Medicine, Department of Internal Medicine Wayne State University, Detroit, MI 48201, USA.
Cohn JA; School of Medicine, Department of Internal Medicine Wayne State University, Detroit, MI 48201, USA; Department of Internal Medicine Wayne State University, Detroit, MI 48201, USA.
Lundahl LH; Department of Psychiatry and Behavioral Neurosciences, USA; School of Medicine, Department of Internal Medicine Wayne State University, Detroit, MI 48201, USA.
Źródło:: Drug and alcohol dependence [Drug Alcohol Depend] 2021 Mar 01; Vol. 220, pp. 108524. Date of Electronic Publication: 2021 Jan 12.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Język:: English
Imprint Name(s):: Publication: Limerick : Elsevier
Original Publication: Lausanne, Elsevier Sequoia.
MeSH Terms:: HIV Infections/*psychology
Marijuana Smoking/*psychology
Adult ; Anxiety ; Cannabis ; Female ; Hallucinogens ; Humans ; Male ; Marijuana Abuse ; Marijuana Use ; Medical Marijuana ; Opioid-Related Disorders ; Pain ; Surveys and Questionnaires
References:: Subst Use Misuse. 2009;44(11):1503-18. (PMID: 19938929)
Neuropsychopharmacology. 2009 Feb;34(3):672-80. (PMID: 18688212)
Psychol Addict Behav. 2011 Jun;25(2):358-64. (PMID: 21443296)
Annu Rev Med. 2016;67:453-66. (PMID: 26515984)
Addiction. 1998 Mar;93(3):321-35. (PMID: 10328041)
J Pain Symptom Manage. 2005 Apr;29(4):358-67. (PMID: 15857739)
Public Health Rev. 2014;35(2):1-18. (PMID: 25642015)
AIDS Patient Care STDS. 1996 Feb;10(1):32-6. (PMID: 11361656)
Exp Clin Psychopharmacol. 2015 Dec;23(6):504-12. (PMID: 26280591)
AIDS. 2001 Mar 9;15(4):532-3. (PMID: 11242154)
Harm Reduct J. 2005 Oct 04;2:18. (PMID: 16202145)
J Psychoactive Drugs. 2000 Oct-Dec;32(4):435-43. (PMID: 11210205)
J Acquir Immune Defic Syndr (1988). 1994 Oct;7(10):1057-63. (PMID: 8083823)
AIDS Behav. 2017 Apr;21(4):1138-1148. (PMID: 27738780)
Exp Clin Psychopharmacol. 2019 Apr;27(2):109-114. (PMID: 30475012)
J Acquir Immune Defic Syndr. 2005 Jan 1;38(1):43-6. (PMID: 15608523)
Drug Alcohol Depend. 2013 Oct 1;132(3):654-9. (PMID: 23683791)
Psychol Rev. 2008 Jan;115(1):186-98. (PMID: 18211190)
AIDS Patient Care STDS. 2013 Sep;27(9):503-10. (PMID: 23991688)
J Health Econ. 2020 Jan;69:102273. (PMID: 31865260)
Drug Alcohol Depend. 2014 Aug 1;141:27-33. (PMID: 24878248)
Addict Behav. 2007 Jan;32(1):49-62. (PMID: 16647822)
J Gen Intern Med. 2019 Aug;34(8):1419-1426. (PMID: 30684198)
AIDS Care. 2023 Jan;35(1):78-82. (PMID: 34743619)
Addict Behav. 2001 Nov-Dec;26(6):803-25. (PMID: 11768546)
Drug Alcohol Depend. 2017 Jan 01;170:174-180. (PMID: 27951424)
J Psychopharmacol. 2020 Jun;34(6):654-662. (PMID: 32267192)
Int Rev Psychiatry. 2018 Oct;30(5):91-106. (PMID: 30522342)
Annu Rev Clin Psychol. 2014;10:641-77. (PMID: 24679180)
Am J Public Health. 2018 Mar;108(3):e12. (PMID: 29412729)
J Acquir Immune Defic Syndr. 2004 Jan 1;35(1):38-45. (PMID: 14707790)
Proc Natl Acad Sci U S A. 2019 Jun 25;116(26):12624-12626. (PMID: 31182592)
Inj Epidemiol. 2019 Sep 02;6:38. (PMID: 31497489)
Addiction. 1996 Sep;91(9):1261-4. (PMID: 8854356)
Am J Drug Alcohol Abuse. 2015 Mar;41(2):166-72. (PMID: 25375878)
B E J Econom Anal Policy. 2010 Feb 17;10(1):. (PMID: 23536916)
Prim Care. 2002 Jun;29(2):361-78. (PMID: 12391716)
Cannabis Cannabinoid Res. 2019 Sep 23;4(3):204-213. (PMID: 31579835)
Psychopharmacology (Berl). 2019 Sep;236(9):2641-2652. (PMID: 30927021)
J Int Assoc Physicians AIDS Care (Chic). 2009 Nov-Dec;8(6):342-6. (PMID: 19952287)
Addict Behav. 2007 Oct;32(10):2238-52. (PMID: 17478056)
JAMA Intern Med. 2014 Oct;174(10):1668-73. (PMID: 25154332)
Drug Alcohol Depend. 2016 Dec 01;169:26-32. (PMID: 27755989)
Eur J Intern Med. 2018 Mar;49:20-22. (PMID: 29482739)
AIDS Care. 2007 Apr;19(4):500-6. (PMID: 17453590)
Drug Alcohol Depend. 2015 Jul 1;152:32-8. (PMID: 26002377)
AIDS Care. 2008 Sep;20(8):1002-18. (PMID: 18608078)
AIDS Patient Care STDS. 2016 Jul;30(7):324-38. (PMID: 27410496)
Neurology. 2007 Feb 13;68(7):515-21. (PMID: 17296917)
J Public Health Policy. 2002;23(4):413-39. (PMID: 12532682)
AIDS Patient Care STDS. 2001 Mar;15(3):159-67. (PMID: 11313029)
J Am Board Fam Med. 2014 Sep-Oct;27(5):583-93. (PMID: 25201928)
Curr HIV/AIDS Rep. 2011 Dec;8(4):223-34. (PMID: 21858414)
Am J Drug Alcohol Abuse. 2019;45(6):644-663. (PMID: 31603710)
Addiction. 2019 Jan;114(1):112-118. (PMID: 30194789)
Behav Processes. 2017 Jul;140:33-40. (PMID: 28347716)
Exp Clin Psychopharmacol. 2014 Jun;22(3):211-21. (PMID: 24467370)
Drug Alcohol Depend. 2014 Jun 1;139:33-40. (PMID: 24745475)
J Acquir Immune Defic Syndr. 2019 Jun 1;81(2):231-237. (PMID: 30865181)
JAMA Intern Med. 2018 May 1;178(5):673-679. (PMID: 29610827)
J Altern Complement Med. 2011 Sep;17(9):789-96. (PMID: 21875350)
Addiction. 2018 Jun;113(6):987-988. (PMID: 29468760)
Int J Drug Policy. 2019 Dec;74:152-159. (PMID: 31590091)
Forum Health Econ Policy. 2019 Oct 16;22(2):. (PMID: 31618173)
Addiction. 2020 May;115(5):817-831. (PMID: 31656048)
Grant Information:: R01 DA032678 United States DA NIDA NIH HHS
Contributed Indexing:: Keywords: Cannabis use disorder; Demand curve analysis; HIV; Marijuana; Opioid; Pain
Substance Nomenclature:: 0 (Hallucinogens)
0 (Medical Marijuana)
Entry Date(s):: Date Created: 20210116 Date Completed: 20210608 Latest Revision: 20240330
Update Code:: 20240330
PubMed Central ID:: PMC7889735
DOI:: 10.1016/j.drugalcdep.2021.108524
PMID:: 33453502
: Czasopismo naukowe

Full Text Finder

Background: Despite medicalization and legalization of marijuana use, factors influencing demand for marijuana among persons living with HIV (PLWH) are incompletely understood. This knowledge gap undermines effective clinical management and policies. This study used demand curve simulation methods to address these issues.
Methods: Marijuana-using PLWH (N = 119) completed experimental tasks to simulate amount of marijuana purchasing/use across different costs (money or time), and likelihood of reselling marijuana or marijuana therapeutic-use registration card in relation to profits. Additional simulations assessed purchasing of marijuana relative to other drug and non-drug goods.
Results: Simulated marijuana use decreased as money and time costs increased. Consumption was greater for participants with more severe Cannabis Use Disorder (CUD) and anxiety, intermediate pain levels, and past 90-day opioid use. Whereas few participants chose to sell their registration card, marijuana resale (diversion) steeply increased with profit. Likelihood of seeking marijuana therapeutic-use certification decreased in relation to registration card money cost, having to visit more physicians to get a signature, and delay to receiving the card, and increased with duration of certification. Participants who reported recent opioid use were more likely to seek certification. Consumption of several commodities assessed was independent of marijuana.
Conclusions: Simulated marijuana use was related to participants' clinical profile (CUD, anxiety and pain symptoms, recent opioid use), and unrelated to purchasing other goods. Likelihood of seeking marijuana therapeutic-use registration was affected by several types of costs and recent opioid use. Participants were unlikely to divert registration cards. We discuss clinical and policy implications of these findings.
(Copyright © 2021 Elsevier B.V. All rights reserved.)

Informacja